{"title":"转移的生物制剂及其对内科的影响","authors":"D. Gandía","doi":"10.37191/mapsci-actcr-1(2)-9","DOIUrl":null,"url":null,"abstract":"Cancer Metastases (Mets), the dissemination and growth of tumor cells at distant sites of the primary tumor, is a very complex Biological and Clinical process, that when intractable, leads most of the times to the patient death. Mets are the Cancer paradigm and is still a “prohibited” word in many parts of the world´s societies [1,2]. Cancer adjuvant or metastases-preventing therapies, such as Chemotherapy (Chemo) and nowadays Immunotherapy (Immune) give impressive survival rates results.","PeriodicalId":223531,"journal":{"name":"Archives of Clinical Trials and Case Reports","volume":"148 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Metastases its Biologics and Impact in Internal Medicine\",\"authors\":\"D. Gandía\",\"doi\":\"10.37191/mapsci-actcr-1(2)-9\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Cancer Metastases (Mets), the dissemination and growth of tumor cells at distant sites of the primary tumor, is a very complex Biological and Clinical process, that when intractable, leads most of the times to the patient death. Mets are the Cancer paradigm and is still a “prohibited” word in many parts of the world´s societies [1,2]. Cancer adjuvant or metastases-preventing therapies, such as Chemotherapy (Chemo) and nowadays Immunotherapy (Immune) give impressive survival rates results.\",\"PeriodicalId\":223531,\"journal\":{\"name\":\"Archives of Clinical Trials and Case Reports\",\"volume\":\"148 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-06-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives of Clinical Trials and Case Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.37191/mapsci-actcr-1(2)-9\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Clinical Trials and Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37191/mapsci-actcr-1(2)-9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Metastases its Biologics and Impact in Internal Medicine
Cancer Metastases (Mets), the dissemination and growth of tumor cells at distant sites of the primary tumor, is a very complex Biological and Clinical process, that when intractable, leads most of the times to the patient death. Mets are the Cancer paradigm and is still a “prohibited” word in many parts of the world´s societies [1,2]. Cancer adjuvant or metastases-preventing therapies, such as Chemotherapy (Chemo) and nowadays Immunotherapy (Immune) give impressive survival rates results.